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Objective: Minimally invasive techniques are increasingly used in gynecological cancer surgery. Although
many studies worldwide have looked at the safety and outcomes of the laparoscopic approach to gy-
necological cancers, there is a lack of data on this subject in our local setting. We therefore reviewed the
safety and morbidity of laparoscopic techniques for gynecological cancers in Singapore's largest gyne-
cological cancer center.
Methods: We carried out a retrospective review of a prospectively maintained database of all patients
from Kerdang Kerbau Women's and Children's Hospital who underwent laparoscopic staging surgery for
gynecological cancers over a 5-year period from January 2008 to December 2012. We obtained infor-
mation on patient demographics, the clinicalepathological features, and perioperative and follow-up
details, including intraoperative and postoperative complication rates, from clinical notes and elec-
tronic records.
Results: In total, 142 patients were included in the study. Ninety-eight patients underwent full staging
surgery for endometrial cancer and 44 patients underwent full staging surgery for cervical cancer. One
hundred and twenty-one operations were laparoscopic hysterectomies and 21 were laparoscopic radical
hysterectomies. The overall conversion rate was 0.7%. The median length of the operation, the length of
stay in hospital, the intraoperative complications, the lymph node yield, and the postoperative
complication rates were comparable with previously published data from other institutions. At a median
follow-up time of 29 months, the recurrence rates were 4.1% and 14.2% for laparoscopic hysterectomy
and laparoscopic radical hysterectomy, respectively.
Conclusion: Laparoscopic surgery for gynecological cancers at our institution is safe, with morbidity
statistics comparable with those of other centers.
Copyright © 2014, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. All rights reserved.Introduction
The advent of minimally invasive techniques has revolutionized
the approach to surgery for gynecological cancers. The use of lap-
aroscopy in endometrial and cervical cancer was ﬁrst proposed by
Childers et al1 and Nezhat et al2 in the 1990s and since then several
randomized trials and meta-analyses have provided evidence that
supports the use of laparoscopic-assisted surgery over traditional
open surgery for early stage cancers. The reported advantages of ats.
oncology, Kerdang Kerbau
oad, Singapore 229899.
Lim).
for Gynecologic Endoscopy and Minimlaparoscopic approach in gynecological cancer surgery include
lower blood loss and transfusion rates, less pain and requirement
for analgesia, faster postoperative recovery times, and earlier
commencement of adjuvant radiotherapy or chemotherapywith no
signiﬁcant compromise in morbidity or risk of recurrence.3e7
Endometrial cancer surgery has historically been performed via
a laparotomy approach. This includes careful survey of the
abdomen and pelvis, peritoneal washing, total abdominal hyster-
ectomy with bilateral salpingo-oophrectomy, and pelvic lympha-
denectomy. This holds true for surgeries dealing with cervical
cancer, with the main difference being that a radical hysterectomy
is performed for the treatment of certain stages of cervical cancer.
Although much work has been carried out worldwide to look at
the outcomes and complications of minimally invasive techniques
in the management of gynecological cancers, there is a lack of localally Invasive Therapy. Published by Elsevier Taiwan LLC. All rights reserved.
Table 1
Baseline characteristics, disease pathology, and duration of follow up for patients
with endometrial cancer (n ¼ 98).
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of minimally invasive techniques in gynecological cancer surgery in
Singapore's largest gynecological cancer center.Age (y) 54 (24e78)
BMI (kg/m2) 25.4 (18.0e44.0)
Categorical BMI
<30 72 (73.4)
30e35 15 (15.4)
>35 11 (11.2)
Race
Chinese 80 (81.6)
Malay 10 (10.2)
Indian 5 (5.1)
Other 3 (3.1)
Number of previous abdominal surgeries
0 72 (73.5)
1 20 (20.4)
2 5 (5.1)
>2 1 (1.0)
Grade of tumor on ﬁnal histology
1 67 (68.3)
2 24 (24.6)
3 7 (7.1)
Stage of disease
1 91 (92.9)
2 1 (1.0)
3 6 (6.1)
4 0 (0)
Histological subtypes
Endometroid adenocarcinoma 90 (91.8)
Serous or clear cell carcinoma 3 (3.1)
Mixed patterns 4 (4.1)
Endometrial stroma sarcoma 1 (1.0)
Duration of follow up (mo) 19.7 (1.5e65.7)
Data are presented as n (%) or median (range).
BMI ¼ body mass index.
Table 2
Baseline characteristics, disease pathology, and duration of follow up for
patients with cervical cancer (n ¼ 44).
Age (y) 47 (30e70)
BMI (kg/m2) 24.1 (17.0e38.7)
Categorical BMI
<30 39 (88.6)
30e35 4 (9.1)
>35 1 (2.3)
Race
Chinese 35 (79.5)
Malay 6 (13.6)
Indian 2 (4.6)
Burmese 1 (2.3)
Number of previous abdominal surgeries
0 35 (79.5)
1 9 (20.5)
Grade of tumor on ﬁnal histology
1 17 (38.6)
2 9 (20.5)
3 5 (11.4)
Ungraded 13 (29.5)
Stage of diseaseMaterials and methods
A retrospective review was carried out of all patients from the
Kerdang Kerbau Women's and Children's Hospital who underwent
laparoscopic staging surgery for gynecological cancer over a 5-year
period from January 2008 to December 2012.
Patients with preinvasive cancers and patients who did not
undergo full surgical staging in the initial procedure were excluded.
This included patients who were incidentally diagnosed with
cancer postoperatively via histology and those who were thought
to be unﬁt for surgery or who did not undergo full staging pro-
cedures for other reasons.
Full surgical staging for endometrial cancer consists of total
hysterectomy, bilateral salpingo-oophorectomy, pelvic lymph node
dissection, and peritoneal washings for cytology. Para-aortic lymph
node dissection and omentectomy may also be performed for high-
grade tumors and serous or clear cell histological subtypes. For
cervical cancer, FIGO clinical early stage 1A1 disease is usually
treated by laparoscopic hysterectomy and bilateral salpingo-
oophorectomy. For FIGO clinical stage 1A2 to 1B1 disease, modi-
ﬁed radical or radical hysterectomy, bilateral salpingo-
oophorectomy, and pelvic lymph node dissection are performed.
More advanced or metastatic cervical cancers are usually treated
with chemoeradiation therapy or palliative care depending on the
stage.
As a standard protocol in our institution, all patients receive
perioperative and postoperative antibiotic prophylaxis as well as
postoperative graduated compression stockings and treatment
with subcutaneous low molecular weight heparin unless
contraindicated.
Patients were identiﬁed from our institution's prospectively
maintained cancer database. Data were obtained through a review
of the patients' medical records and the electronic records where
applicable. The data collated included patient demographics, the
pathology of the disease, the length of follow up, and also operative
information, including operating room time, estimated blood loss,
requirement for transfusion, lymph node count, the need for con-
version to laparotomy and indications for doing so, length of hos-
pital stay, pain score based on the WongeBaker facial pain scale,
and timing to ﬁrst diet of choice. All operative and postoperative
complications related to the operation were recorded. Any unex-
pected or unplanned event requiring intraoperative or post-
operative intervention was deﬁned as a complication.
Postoperative complications were broadly classiﬁed into two cat-
egories of early and late complications. A duration of 1 month was
used to discriminate between the two categories. Where appli-
cable, all complications were graded according to the Clavien
classiﬁcation.8 Complications of grade 2 and abovewere considered
during the analysis of postoperative complications to facilitate
comparison with other studies that deﬁned postoperative compli-
cations in a similar manner.1A1 21 (47.7)
1A2 2 (4.6)
1B1 20 (45.5)
1B2 1 (2.3)
Histological subtypes
Squamous 27 (61.4)
Adenocarcinoma 14 (31.8)
Mixed 3 (6.8)
Duration of follow up (mo) 28.6 (0.5e56.9)
Data are presented as n (%) or median (range).
BMI ¼ body mass index.Results
A total of 142 patients were identiﬁed for inclusion in the study.
Of these, 98 patients underwent full staging surgery for endome-
trial cancer and 44 for cervical cancer. One hundred and twenty-
one patients had a laparoscopic hysterectomy and 21 had a lapa-
roscopic radical hysterectomy. All operations were performed by a
consultant gyne-oncologist in our center. Tables 1 and 2 show thebaseline characteristics, demographics, disease pathology, and
duration of follow up for each group of patients.
Table 3 gives the number of patients that underwent the various
types of operation for the two types of cancer. A total of 91.8% of
Table 3
Type of laparoscopic surgery for each cancer group.
n (%)
TLHþ/ BSO BPLND 90 (91.8)
TLHþ/ BSO BPLND PAND þ/ omentectomy 6 (6.1)
Modiﬁed radical or radical hysterectomy BSO BPLND 2 (2.0)
TLH þ/ BSO 25 (56.8)
Radical hysterectomy þ/ BSO BPLND 17 (38.6)
Modiﬁed radical hysterectomy þ/ BSO lymph node sampling 2 (4.6)
BPLND ¼ bilateral pelvic lymphadenectomy; BSO ¼ bilateral salpingo-
oophorectomy; PAND ¼ para-aortic lymphadenectomy; TLH ¼ laparoscopic
hysterectomy.
Table 5
Postoperative complications.
Hysterectomy
(n ¼ 121)
Radical hysterectomy
(n ¼ 21)
Early (within 1 mo)
Major
Intestinal obstruction 1 (0.8) 0 (0)
Urinary tract injury 1 (0.8) 0 (0)
Vaginal vault bleeding 1 (0.8) 0 (0)
Fistula 0 (0) 1 (4.8)
Cardiovascular events 0 (0) 0 (0)
Venous thrombolic events 0 (0) 0 (0)
Minor
Fever (>38.0C) 3 (2.5) 1 (4.8)
Nausea and vomiting 4 (3.3) 0 (0)
Ileus 1 (0.8) 0 (0)
Infection, total 4 (3.3) 1 (4.8)
Skin 2 (1.7) 0 (0)
Upper respiratory tract 1 (0.8) 0 (0)
Urinary tract 1 (0.8) 1 (4.8)
Voiding dysfunction 3 (2.5) 4 (19.0)
Vault hematoma/dehiscence 1 (0.8) 0 (0)
Subcutaneous emphysema/
pneumomediastinum
0 (0) 0 (0)
Late (after 1 mo)
Major
Lymphoedema requiring surgery 1 (0.8) 0 (0)
Minor
Lymphocyst/lymphatic leakage 2 (1.7) 2 (9.5)
Voiding dysfunction 3 (0.8) 4 (19.0)
Total patients with complications 15 (12.4) 6 (28.6)
Data are presented as n (%).
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scopic hysterectomy with or without bilateral salpingo-
oophorectomy and bilateral pelvic lymphadenectomy. Five pa-
tients had an additional para-aortic lymphadenectomy and
omentectomy for serous or clear cell endometrial cancers and two
patients underwent radical hysterectomy for endometrial cancers
with cervical involvement. For the group with cervical cancer,
56.8% of patients underwent laparoscopic hysterectomy with or
without bilateral salpingo-oophorectomy for early stage 1A1 cer-
vical cancer. The remaining patients (43.2%) with FIGO clinical stage
1A2 to 1B1 cervical cancer underwent modiﬁed radical or radical
hysterectomy with or without bilateral salpingo-oophorectomy
and bilateral pelvic lymph node dissection.
The perioperative data, postoperative course, and postoperative
complications were analyzed based on the type of operation per-
formed (hysterectomyversus radical hysterectomy) (Tables 4 and5).
One patient in the laparoscopic hysterectomy groupwas changed to
a minilaparotomy as the specimen could not be delivered vaginally
as a result of the patient's nulliparous status. Among the patients
who underwent laparoscopic hysterectomy, only one patient had an
intraoperative complication of serosal injury to the bladder and this
was repaired immediately during the same operation. There was no
intraoperative complication in the laparoscopic radical hysterec-
tomy group. The majority of patients in both groups managed to
successfully commence their diet of choice on the 2nd postoperative
dayand reported goodpain control.Medianpain scoreswere2/10 at
the 2-hour postoperative review and continued to decrease withTable 4
Perioperative data, length of hospital stay, timing of ﬁrst diet of choice, and pain
score for patients.
Data Hysterectomy
(n ¼ 121)
Radical hysterectomy
(n ¼ 21)
ORT (min) 190 (114e364) 273 (192e480)
EBL (mL) 93 (0e1200) 311 (0e850)
No. of lymph nodes removed 25 (3e47) 26 (0e49)
No. of conversions 1 (0.8) 0 (0)
Intraoperative visceral organ injury 1 (0.8) 0 (0)
Transfusions 1 (0.8) 1 (4.7)
LOS (d) 3 (2e27) 4 (3e16)
Median timing of ﬁrst DOC (d) 2 2
Categorical timing of ﬁrst DOC
Day 1 23 (19.0) 0 (0)
Day 2 62 (51.2) 14 (66.7)
Day 3 31 (25.6) 6 (28.6)
Day 4 or later 5 (4.2) 1 (4.7)
Pain score after surgery
2 h 2 (0e7) 2 (0e4)
6 h 1 (0e7) 1 (0e8)
12 h 1 (0e4) 1 (0e3)
24 h 1 (0e3) 1 (0e4)
48 h 0 (0e2) 1 (0e2)
Data are presented as n (%) or median (range).
DOC ¼ diet of choice; EBL ¼ estimated blood loss; LOS ¼ length of stay in hospital;
ORT ¼ operating room time.time. The median duration of hospital stay was 3 days for the hys-
terectomy group and 4 days for the radical hysterectomy group.
There were no perioperative deaths in the studied cohort. In
terms of postoperative complications, 25 events occurred in 15
patients in the hysterectomy group. In two patients, a second
operation was necessary. One patient underwent resuturing of the
vaginal vault for persistent vaginal bleeding and the other needed a
hernia repair for a port site hernia complicated by subacute intes-
tinal obstruction. One patient was presumed to have sustained a
transient ureteric injury as she was found on evaluation to have
renal impairment associated with a new right-sided hydro-
nephrosis. Shewas referred to a urologist andmanaged expectantly
with restoration of normal renal function 1 month after the
operation.
For the radical hysterectomy group, 13 events occurred in six
patients. One complication was major and occurred in a patient
who developed an ureteroevaginal ﬁstula diagnosed 10 days
postoperatively. She subsequently had a permanent DJ stent
inserted. Her postoperative recovery was also complicated by
problems of urinary tract infection, probably associated with the
presence of the ﬁstula.
In both groups, there were no cardiovascular events, pulmonary
embolisms, deep vein thromboses, subcutaneous emphysema, or
pneumomediastinum. The most common late complication in both
groups was low-grade lymphedema managed conservatively with
physiotherapy and compression stockings. This occurred in 12 pa-
tients in the hysterectomy group and four patients in the radical
hysterectomy group. These patients were not included in the
analysis of postoperative complications (Table 5) as they were
grade 1 morbidities. However, one patient who underwent a
laparoscopic hysterectomy for endometrial cancer developed
lymphedema complicated by episodes of recurrent cellulitis, which
required admission to hospital and treatment with intravenous
antibiotics. She eventually underwent surgery and had vascularized
lymph node transfer for treatment of her lymphedema.
Table 6
Laparoscopic outcomes in randomized prospective studies and systematic reviews for laparoscopic hysterectomies.
Reference n ORT (min) LOS (d) EBL (mL) No. of LN
removed
Conversion
rate (%)
Intraoperative
complications (%)
Postoperative
complications (%)
Recurrence
rate (%)
Walker et al7 1696 204 2 NR 17 25.8 10 14 11.6
Mourits et al13 185 115 3 100 NR 10.8 5 11.9 NR
Malzoni et al14 81 136 2.1 50 23.5 0 NR NR 8.6
Magrina et al15 945 171 3.5 216 16.2 1.8 4.2 12.2 8.6
Zullo et al16 40 197 3 174 11.5 12.5 7.5 27.5 22.5
Tozzi et al17 63 NR 7.8 241 28.6 7.9 4.7 31.7 12.6
Our institution 121 190 3 93 25 0.8 0.8 12.4 4.1
EBL ¼ estimated blood loss; LN ¼ lymph node; LOS ¼ length of stay in hospital; NR ¼ not reported; ORT ¼ operating room time.
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hysterectomy groups were 4.1% and 14.2%, respectively. In the
hysterectomy group, one patient with a port site recurrence was
reported. This patient had undergone laparoscopic hysterectomy,
bilateral salpingo-oophorectomy, pelvic lymph node dissection,
and postoperative radiotherapy for stage 1b grade 1 endometroid
adenocarcinoma of the endometrium. Her cancer recurred 28
months later in the form of port site metastasis and she is currently
receiving treatment with Megace. The other sites of recurrence in
the hysterectomy group included the pelvic lymph nodes, lungs,
and vaginal vault. The sites of recurrence in the radical hysterec-
tomy group included the vaginal vault, peritoneum, pelvic side
walls, and liver.
The survival rate for the patients with endometrial cancer was
100% with a median duration of follow up of 23 months (Table 2),
with six patients being lost to follow up. One patient in the cervical
cancer group died 2 years and 3 months after her operation. She
was initially diagnosed with stage 1b1 cervical cancer and was
disease-free for 14 months before she had a recurrence of the
cancer in the liver and peritoneum.
Discussion
The use of laparoscopy in endometrial and cervical cancer sur-
gery was ﬁrst proposed in the 1990s and, since then, several ran-
domized trials and meta-analyses have provided evidence that
supports the use of laparoscopic-assisted surgery over traditional
open surgery for early stage gynecological cancers. The ﬁrst lapa-
roscopic operation for gynecological cancer was performed in our
institution in the year 2000. Since then, the practice of minimally
invasive surgery for these cancers has become more commonplace
in our institution for suitable patients, with a background of
appropriate patient selection.
With speciﬁc attention to endometrial and cervical cancers,
multiple randomized trials have been performed comparing the
morbidity of a laparoscopic approach versus a conventional lapa-
rotomy approach. Tables 6 and 7 give the perioperative and
morbidity outcomes for laparoscopic surgery in some of these
studies. The results of our study are included in the tables for
comparison.Table 7
Laparoscopic outcomes in randomized prospective studies and systematic reviews for la
Reference n ORT (min) LOS (d) EBL (mL) No. of LN
removed
Conv
rate
Geetha and Nair18 1339 264 3.8 209 21.6 NR
Pellegrino et al19 107 305 4 200 26 5.6
Magrina et al20 31 216 2 208 25 0
Spirtos et al21 78 205 NR 225 34.1 3.8
Our institution 21 273 4 311 26 0
EBL ¼ estimated blood loss; LN ¼ lymph node; LOS ¼ length of stay in hospital; NR ¼ nIn terms of operating time, length of hospital stay, and lymph
node yield, results from laparoscopic hysterectomy and radical
hysterectomy were comparable with those of other institutions.
The estimated blood loss and positive margin status in the radical
hysterectomy group were higher than at other institutions.
Although the results may be skewed due to our relatively small
sample size, a possible contributory factor could be the steeper
learning curve for surgeons performing a laparoscopic radical
hysterectomy compared with a laparoscopic hysterectomy.
Intraoperative complications were low in our study, with only
one patient sustaining a visceral organ injury (serosal injury to the
bladder), which was repaired promptly during the same operation.
Only one patient required conversion to a minilaparotomy because
the hysterectomy specimenwas unable to be delivered vaginally as
a result of her nulliparous status. This low rate of conversion of
0.80%, which is much lower than that reported previously, is
probably a result of the stringent patient selection criteria within
our institution. In addition, differences in patient demographics
may also contribute to these differences in conversion rates, in
particular with regard to the body mass index (BMI). In our study,
the median BMI was 25.4 and 24.1 for endometrial and cervical
cancer, respectively. This compares with a slightly higher median
BMI in Western series, ranging from 26 to 28, which may, in some
patients, impede safe completion of the operation via a laparo-
scopic approach.
The total postoperative complication rates at our center were
12.4% and 28.6% for the hysterectomy and radical hysterectomy
groups, respectively. This is largely comparable with those pub-
lished previously. Most of the postoperative complications in the
radical hysterectomy group were attributed to voiding dysfunction,
which occurred in four (19%) patients. Although this appears to be a
large proportion, the value is at the lower range of that expected in
an open radical hysterectomy, where the incidence of voiding
dysfunction ranges from 20% to 50%.9,10
Concerns remain regarding the adequacy of oncological
clearance with minimally invasive techniques compared with
open surgery and whether the laparoscopic approach affects
recurrence and survival rates. The LAP2 study aimed to look at
this issue.6 In this study, 2616 women were randomized to either
laparoscopy (n ¼ 1696) or laparotomy (n ¼ 920) for endometrialparoscopic radical hysterectomy.
ersion
(%)
Intraoperative
complications (%)
Postoperative
complications (%)
Positive/close
margins (%)
Recurrence
rate (%)
NR 15 0 2.8
1.9 22.4 8.4 14.1
3 19.3 NR NR
5.1 26.2 3.84 10.3
0 28.6 9.5 14.2
ot reported; ORT ¼ operating room time.
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salpingo-oophorectomy, and pelvic/para-aortic lymphadenec-
tomy. The main study endpoint was noninferiority for
recurrence-free survival. The results from the study showed 3-
year recurrences rate of 11.4% and 10.2% in the laparoscopic
and laparotomy group, respectively. The estimated 5-year overall
survival was almost identical at 89.8% in both groups. This study
thus concluded that laparoscopic surgery was not inferior to
laparotomy in terms of recurrence and survival rates. At our
institution, the overall survival rate was 100% with a 5% rate of
cancer recurrence to date. However, the median duration of
follow up in our study is only approximately 2 years. This pre-
cludes meaningful comparison of our ﬁndings with other studies.
Efforts are ongoing to continue collecting data to further analyze
the outcomes and survival rates when an adequate duration of
follow up has been achieved.
Many retrospective series have addressed the concerning
issue of port site metastases in women undergoing laparoscopic
procedures for gynecological cancers. However, the true inci-
dence of this complication is unknown. A 12-year study of 1288
patients who underwent minimally invasive surgery for gyne-
cological cancers found a port site metastasis rate of 0.97%.11
However, these patients had gynecological cancers that
included not only endometrial and cervical cancers, but also
ovarian cancers. Another retrospective study of 105 laparoscopic
operations for gynecological cancers found a similar rate of 1%
for abdominal wall tumor implantation.12 As the incidence of this
complication is low, it is difﬁcult to draw conclusive results
from the various published reports. In our retrospective study,
we saw one patient with port site metastasis among the 142
patients who underwent laparoscopic surgery for gynecological
cancer, giving a rate of 0.7%, which is consistent with the low rate
of this particular complication observed in previously published
reports.
Conclusion
To our knowledge, this is one of only a few studies in
Singapore looking at the outcomes and complication rates of
laparoscopic surgery for gynecological cancers. It appears that
this approach to surgery for endometrial and cervical cancers in
our institution is safe, with morbidity rates and outcomes com-
parable with data published previously by other centers. In the
setting of good patient selection, it is a technique which should
be considered as part of the surgical armamentarium of a gyne-
oncologist for the surgical treatment of cervical and endometrial
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